| Identification and characterization of ovarian cancer-initiating cells from primary human tumors S Zhang, C Balch, MW Chan, HC Lai, D Matei, JM Schilder, PS Yan, ... Cancer research 68 (11), 4311-4320, 2008 | 1381 | 2008 |
| Rethinking ovarian cancer: recommendations for improving outcomes S Vaughan, JI Coward, RC Bast, A Berchuck, JS Berek, JD Brenton, ... Nature Reviews Cancer 11 (10), 719-725, 2011 | 1141 | 2011 |
| Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer DD Bowtell, S Böhm, AA Ahmed, PJ Aspuria, RC Bast, V Beral, JS Berek, ... Nature reviews Cancer 15 (11), 668-679, 2015 | 630 | 2015 |
| EGFR and MET receptor tyrosine kinase–altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers M Garofalo, G Romano, G Di Leva, G Nuovo, YJ Jeon, A Ngankeu, J Sun, ... Nature medicine 18 (1), 74-82, 2012 | 403 | 2012 |
| MicroRNA cluster 221-222 and estrogen receptor α interactions in breast cancer G Di Leva, P Gasparini, C Piovan, A Ngankeu, M Garofalo, C Taccioli, ... JNCI: Journal of the National Cancer Institute 102 (10), 706-721, 2010 | 357 | 2010 |
| MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways X Rao, G Di Leva, M Li, F Fang, C Devlin, C Hartman-Frey, ME Burow, ... Oncogene 30 (9), 1082-1097, 2011 | 349 | 2011 |
| Epigenetic resensitization to platinum in ovarian cancer D Matei, F Fang, C Shen, J Schilder, A Arnold, Y Zeng, WA Berry, ... Cancer research 72 (9), 2197-2205, 2012 | 302 | 2012 |
| Diverse gene expression and DNA methylation profiles correlate with differential adaptation of breast cancer cells to the antiestrogens tamoxifen and fulvestrant M Fan, PS Yan, C Hartman-Frey, L Chen, H Paik, SL Oyer, JD Salisbury, ... Cancer research 66 (24), 11954-11966, 2006 | 250 | 2006 |
| Epigenetic gene silencing in cancer initiation and progression KP Nephew, THM Huang Cancer letters 190 (2), 125-133, 2003 | 242 | 2003 |
| Alcohol exposure alters DNA methylation profiles in mouse embryos at early neurulation Y Liu, Y Balaraman, G Wang, KP Nephew, FC Zhou Epigenetics 4 (7), 500-511, 2009 | 237 | 2009 |
| Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markers SH Wei, CM Chen, G Strathdee, J Harnsomburana, CR Shyu, ... Clinical Cancer Research 8 (7), 2246-2252, 2002 | 224 | 2002 |
| Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer YW Leu, PS Yan, M Fan, VX Jin, JC Liu, EM Curran, WV Welshons, ... Cancer research 64 (22), 8184-8192, 2004 | 210 | 2004 |
| Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-α responsive promoters ASL Cheng, VX Jin, M Fan, LT Smith, S Liyanarachchi, PS Yan, YW Leu, ... Molecular cell 21 (3), 393-404, 2006 | 200 | 2006 |
| Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer M Li, C Balch, JS Montgomery, M Jeong, JH Chung, P Yan, THM Huang, ... BMC medical genomics 2 (1), 1-13, 2009 | 194 | 2009 |
| MicroRNA and mRNA integrated analysis (MMIA): a web tool for examining biological functions of microRNA expression S Nam, M Li, K Choi, C Balch, S Kim, KP Nephew Nucleic acids research 37 (suppl_2), W356-W362, 2009 | 182 | 2009 |
| The epigenetics of ovarian cancer drug resistance and resensitization C Balch, THM Huang, R Brown, KP Nephew American journal of obstetrics and gynecology 191 (5), 1552-1572, 2004 | 180 | 2004 |
| Triple analysis of the cancer epigenome: an integrated microarray system for assessing gene expression, DNA methylation, and histone acetylation H Shi, SH Wei, YW Leu, F Rahmatpanah, JC Liu, PS Yan, KP Nephew, ... Cancer research 63 (9), 2164-2171, 2003 | 179 | 2003 |
| Epithelial ovarian cancer experimental models E Lengyel, JE Burdette, HA Kenny, D Matei, J Pilrose, P Haluska, ... Oncogene 33 (28), 3619-3633, 2014 | 177 | 2014 |
| CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptor-α M Fan, A Park, KP Nephew Molecular endocrinology 19 (12), 2901-2914, 2005 | 175 | 2005 |
| EGFR signaling in breast cancer: bad to the bone J Foley, NK Nickerson, S Nam, KT Allen, JL Gilmore, KP Nephew, ... Seminars in cell & developmental biology 21 (9), 951-960, 2010 | 168 | 2010 |
Pearlly YanResearch Assistant Professor, The Ohio State UniversityVerifierad e-postadress på osumc.edu
